These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18656518)

  • 21. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
    Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
    Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.
    Gipson CL; Davis NL; Johnston RE; de Silva AM
    Vaccine; 2003 Sep; 21(25-26):3875-84. PubMed ID: 12922122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.
    Tonkin DR; Jorquera P; Todd T; Beard CW; Johnston RE; Barro M
    Vaccine; 2010 Apr; 28(18):3238-46. PubMed ID: 20184975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice.
    Kimoto T; Kim H; Sakai S; Takahashi E; Kido H
    Vaccine; 2019 Jan; 37(4):612-622. PubMed ID: 30553569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
    Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
    Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
    Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
    Vander Veen RL; Loynachan AT; Mogler MA; Russell BJ; Harris DL; Kamrud KI
    Vaccine; 2012 Mar; 30(11):1944-50. PubMed ID: 22269873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.
    Ben Ahmeida ET; Jennings R; Erturk M; Potter CW
    Arch Virol; 1992; 125(1-4):71-86. PubMed ID: 1642561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.
    Davis NL; Brown KW; Johnston RE
    J Virol; 1996 Jun; 70(6):3781-7. PubMed ID: 8648713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge.
    Thornburg NJ; Ray CA; Collier ML; Liao HX; Pickup DJ; Johnston RE
    Virology; 2007 Jun; 362(2):441-52. PubMed ID: 17292434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.
    Konopka JL; Thompson JM; Whitmore AC; Webb DL; Johnston RE
    J Virol; 2009 Dec; 83(23):12432-42. PubMed ID: 19793821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes.
    Suter R; Summerfield A; Thomann-Harwood LJ; McCullough KC; Tratschin JD; Ruggli N
    Vaccine; 2011 Feb; 29(7):1491-503. PubMed ID: 21184857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
    Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
    PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    Sia ZR; Chiem K; Huang WC; Seffouh A; Teimouri Dereshgi A; Hogan T; Ortega J; Davidson BA; Martinez-Sobrido L; Lovell JF
    J Virol; 2022 Oct; 96(19):e0100622. PubMed ID: 36106872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects.
    Osada T; Berglund P; Morse MA; Hubby B; Lewis W; Niedzwiecki D; Yang XY; Hobeika A; Burnett B; Devi GR; Clay TM; Smith J; Kim Lyerly H
    Cancer Immunol Immunother; 2012 Nov; 61(11):1941-51. PubMed ID: 22488274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.
    Thompson JM; Nicholson MG; Whitmore AC; Zamora M; West A; Iwasaki A; Staats HF; Johnston RE
    J Immunol; 2008 Jul; 181(1):574-85. PubMed ID: 18566424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.